CARE Upgrades Corona Remedies Short-Term Facilities to CARE A1+
Corona Remedies Ltd · Others (Uncategorized) · 01 Oct 2026, 12:46 am
CARE Upgrades Corona Remedies Short-Term Facilities to CARE A1+ CARE Ratings has revised and upgraded Corona Remedies Limited's ratings following a review of FY26 audited and Q1FY27 unaudited performance. The company’s long-term/short-term bank facilities of ₹70.00 crore were upgraded to CARE A+; Stable / CARE A1+ from CARE A+; Stable / CARE A1. Concurrently, ratings for long-term bank facilities of ₹7.00 crore (reduced from ₹25.00 crore) were reaffirmed at CARE A+; Stable. Total rated bank facilities stand at ₹77.00 crore.
Original exchange filing (PDF)
More announcements from Corona Remedies Ltd
- Intimation of Participation in Analyst / Investor Conference · 16 Nov 2026
- Intimation of Participation in Analyst / Investor Conference · 07 Nov 2026
- Transcript of Earnings Call with Analyst / Investor on Unaudited Financial Results for the second quarter and half year ended September 30, 2026 · 05 Nov 2026
- Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 · 04 Nov 2026
- Audio Recording of Q2H1FY27 Earnings Conference Call with Analysts / Investors · 02 Nov 2026
- Intimation for Analyst / Investor Meet · 31 Oct 2026
- Analyst / Investor Presentation · 31 Oct 2026
- Press Release on Financial Results for second quarter and half year ended on September 30, 2026 · 31 Oct 2026
